News

FDA greenlights first blood test to diagnose Alzheimer's disease
FDA approves Lumipulse G, the first blood test that can help in the diagnosis of Alzheimer's disease. Read more here.
FDA greenlights marketing of first Alzheimer's blood test for some patients
Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...
SF Weekly15h
FDA Gives Marketing Nod to Blood Test for Diagnosing Alzheimer Disease
The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance ...
FDA clears first blood test to detect Alzheimer's disease. What to know about Lumipulse.
The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.
STAT17h
FDA clears first blood test for diagnosing Alzheimer’s
The FDA has approved the first blood test for diagnosing Alzheimer’s disease, which could speed the path to treatment for ...
First blood test for Alzheimer’s diagnosis cleared by FDA
The FDA has cleared the first-ever blood test for early Alzheimer's detection, which the agency says reduces the need for ...
New blood test for Alzheimer's approved by FDA
The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in ...
FDA endorses first-of-its-kind blood test for Alzheimer’s disease
The Food and Drug Administration cleared a new kind of test for Alzheimer’s disease designed to be more accessible and less ...
Medscape19h
FDA Clears First Diagnostic Blood Test for Alzheimer's Disease
The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio is for the early detection of amyloid plaques associated with Alzheimer’s disease in symptomatic adults 55 years and older.